Results 191 to 200 of about 753,489 (305)

Endoscopic Iliotibial Band Lengthening and Bursectomy Effectively Improve Pain and Function in Patients With Greater Trochanteric Pain Syndrome

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To evaluate patient‐reported outcomes after endoscopic bursectomy and iliotibial band lengthening for the treatment of greater trochanteric pain syndrome. Methods Patients >18 years who underwent endoscopic bursectomy and iliotibial band lengthening for treatment of greater trochanteric pain syndrome were included.
Ashlyn A. Callan   +6 more
wiley   +1 more source

Genetic and population analyses implicate thyroid‐related regulation of RNF144B in chondrocalcinosis

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives Chondrocalcinosis, characterized by calcium crystal deposition within articular cartilage, affects 5–15% of the general population and has recently been identified as an osteoarthritis risk factor. However, Its biological pathways remain unclear.
Yahong Wu   +15 more
wiley   +1 more source

Complement Activation Linked to Type II Interferon Signaling in Still Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Still disease (SD) is an autoinflammatory syndrome characterized by innate immune dysregulation. Although complement can drive inflammation, its involvement in SD remains to be defined. Thus, we aimed to assess complement activation in SD. Methods Complement was assessed using transcriptomic, proteomic, and in vitro approaches. RNA sequencing
Freya M. C. H. Huijsmans   +115 more
wiley   +1 more source

Single‐cell RNA sequencing of peripheral blood defines two immunological subtypes of Sjögren's disease distinguished by anti‐SSA antibodies and aberrant B cell populations

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives Sjögren's disease (SjD) is a heterogeneous autoimmune disorder characterized by substantial clinical and molecular diversity. This heterogeneity raises key questions regarding the existence of distinct pathogenic mechanisms underlying disease subtypes.
Geoffrey Urbanski   +15 more
wiley   +1 more source

TriNetX LATAM Collaborative Network, an EHR Data Source in Latin America. [PDF]

open access: yesPharmacoepidemiol Drug Saf
Pinho V   +4 more
europepmc   +1 more source

Impact of Dual Interleukin‐17A and Interleukin‐17F Inhibition with Bimekizumab on Inflammatory and Structural Lesions in Axial Spondyloarthritis: MRI and Radiographic Outcomes from the Phase 3 BE MOBILE 1 and 2 Studies and their Open‐Label Extension

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives To evaluate the impact of bimekizumab, a dual IL‐17A and IL‐17F inhibitor, on sacroiliac joint (SIJ) and spine inflammation/structural damage in axSpA using MRIs/radiographs from the phase 3 studies BE MOBILE 1 (nr‐axSpA) and 2 (r‐axSpA) and their open‐label extension (OLE).
Walter P. Maksymowych   +10 more
wiley   +1 more source

Doctor Román Piña Chan

open access: yesAnales de Antropología, 2010
Beatriz Barba de Piña Chan
doaj   +1 more source

Case - Penile mycobacterium avium complex infection. [PDF]

open access: yesCan Urol Assoc J
Puerto Nino AK   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy